Publication
Remote versus In-Office Monitoring for Implantable Cardioverter Defibrillators: Results from a Randomized Pragmatic Controlled Study in Portugal
| dc.contributor.author | Martins Oliveira, M | |
| dc.contributor.author | Fernandes, M | |
| dc.contributor.author | Reis, H | |
| dc.contributor.author | Primo, J | |
| dc.contributor.author | Sanfins, V | |
| dc.contributor.author | Silva, V | |
| dc.contributor.author | Silva Cunha, P | |
| dc.contributor.author | Silva, M | |
| dc.contributor.author | Nicola, P | |
| dc.contributor.author | PORTLink Study Investigators | |
| dc.date.accessioned | 2023-02-01T16:04:59Z | |
| dc.date.available | 2023-02-01T16:04:59Z | |
| dc.date.issued | 2022-12 | |
| dc.description.abstract | Introduction: Remote monitoring (RM) is a safe and effective alternative to in-office conventional follow-up. Objective: We aimed to evaluate patient satisfaction with RM and its impact on healthcare resources in a population with cardiac implantable electronic devices. Methods: Randomized, pragmatic, open-label controlled trial, with adult wearers of implantable cardioverter-defibrillator (ICD) or cardiac resynchronization therapy with ICD (CRT-D), eligible for the CareLink® system. Patients newly implanted or with previous conventional follow-up were randomized to RM or conventional follow-up (control), and followed for 12 months, according to the centers' practice. The number of in-office visits and adverse events were compared between groups. Patient and healthcare professionals' satisfaction with RM were described. Results: Of the 134 randomized patients (69 RM; 65 control, aged 60±13 years), 80% were male, 23% employed, 72% ICD wearers and 54% newly implanted. Most patients (70%) reported travel costs less than 15€/visit, and 46% daily routine interference with in-office visits. Median physician/technician time with patient was 15 min/15 min, per in-office visit. Excluding baseline and final visits, control patients had more in-office visits in total: median 1 vs. 0, p<0.001. In 81% of the in-office visits, no clinical measures were taken. There were 10 adverse events, with no differences between groups. At the final visit, 95% of RM patients considered RM easy/very easy to use, and would all prefer to maintain RM and recommend it to others. All professionals found the CareLink website easy/very easy to use and were satisfied with transmission data. Conclusions: In a Portuguese population with ICD and CRT-D, RM safely reduced the burden of in-office visits, with high levels of satisfaction among patients and healthcare professionals. | pt_PT |
| dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
| dc.identifier.citation | Rev Port Cardiol. 2022;41(12):987-997. | pt_PT |
| dc.identifier.doi | 10.1016/j.repc.2021.08.017. | pt_PT |
| dc.identifier.uri | http://hdl.handle.net/10400.17/4382 | |
| dc.language.iso | eng | pt_PT |
| dc.peerreviewed | yes | pt_PT |
| dc.publisher | Elsevier España | pt_PT |
| dc.subject | HSM CAR | pt_PT |
| dc.subject | Adult | pt_PT |
| dc.subject | Female | pt_PT |
| dc.subject | Male | pt_PT |
| dc.subject | Humans | pt_PT |
| dc.subject | Cardiac Resynchronization Therapy* | pt_PT |
| dc.subject | Defibrillators, Implantable* / adverse effects | pt_PT |
| dc.subject | Portugal | pt_PT |
| dc.title | Remote versus In-Office Monitoring for Implantable Cardioverter Defibrillators: Results from a Randomized Pragmatic Controlled Study in Portugal | pt_PT |
| dc.title.alternative | Monitoração Remota versus Seguimento Hospitalar Presencial em Portadores de Cardioversor-Desfibrilhador: Resultados dum Estudo Randomizado em Portugal | pt_PT |
| dc.type | journal article | |
| dspace.entity.type | Publication | |
| oaire.citation.endPage | 997 | pt_PT |
| oaire.citation.startPage | 987 | pt_PT |
| oaire.citation.title | Revista Portuguesa de Cardiologia | pt_PT |
| oaire.citation.volume | 41 | pt_PT |
| rcaap.rights | openAccess | pt_PT |
| rcaap.type | article | pt_PT |